274 related articles for article (PubMed ID: 25426579)
1. ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.
Yildirim E; Connor DA; Gould TJ
Behav Pharmacol; 2015 Apr; 26(3):241-8. PubMed ID: 25426579
[TBL] [Abstract][Full Text] [Related]
2. Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors.
Yohn NL; Turner JR; Blendy JA
J Pharmacol Exp Ther; 2014 May; 349(2):348-54. PubMed ID: 24627467
[TBL] [Abstract][Full Text] [Related]
3. Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats.
Lee AM; Arreola AC; Kimmey BA; Schmidt HD
Behav Brain Res; 2014 Nov; 274():168-75. PubMed ID: 25128791
[TBL] [Abstract][Full Text] [Related]
4. Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus.
Wilkinson DS; Turner JR; Blendy JA; Gould TJ
Psychopharmacology (Berl); 2013 Jan; 225(1):201-8. PubMed ID: 22836371
[TBL] [Abstract][Full Text] [Related]
5. Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning.
Portugal GS; Kenney JW; Gould TJ
Neurobiol Learn Mem; 2008 Feb; 89(2):106-13. PubMed ID: 17584502
[TBL] [Abstract][Full Text] [Related]
6. Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.
Radek RJ; Robb HM; Stevens KE; Gopalakrishnan M; Bitner RS
J Pharmacol Exp Ther; 2012 Dec; 343(3):736-45. PubMed ID: 22988063
[TBL] [Abstract][Full Text] [Related]
7. The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.
Gould TJ; Portugal GS; André JM; Tadman MP; Marks MJ; Kenney JW; Yildirim E; Adoff M
Neuropharmacology; 2012 Apr; 62(5-6):2118-25. PubMed ID: 22285742
[TBL] [Abstract][Full Text] [Related]
8. Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors.
Raybuck JD; Gould TJ
Eur J Neurosci; 2009 Jan; 29(2):377-87. PubMed ID: 19200240
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal From Chronic Nicotine Reduces Thyroid Hormone Levels and Levothyroxine Treatment Ameliorates Nicotine Withdrawal-Induced Deficits in Hippocampus-Dependent Learning in C57BL/6J Mice.
Leach PT; Holliday E; Kutlu MG; Gould TJ
Nicotine Tob Res; 2015 Jun; 17(6):690-6. PubMed ID: 25358661
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear.
Gould TJ; Wilkinson DS; Yildirim E; Blendy JA; Adoff MD
Brain Res; 2014 Apr; 1559():1-10. PubMed ID: 24594018
[TBL] [Abstract][Full Text] [Related]
11. Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning.
Portugal GS; Gould TJ
Pharmacol Biochem Behav; 2007 Dec; 88(2):179-87. PubMed ID: 17868796
[TBL] [Abstract][Full Text] [Related]
12. The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.
Wilkinson DS; Gould TJ
Behav Brain Res; 2011 Sep; 223(1):53-7. PubMed ID: 21514327
[TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
[TBL] [Abstract][Full Text] [Related]
14. Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.
Raybuck JD; Portugal GS; Lerman C; Gould TJ
Behav Neurosci; 2008 Oct; 122(5):1166-71. PubMed ID: 18823172
[TBL] [Abstract][Full Text] [Related]
15. beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice.
Davis JA; Gould TJ
Psychopharmacology (Berl); 2007 Feb; 190(3):343-52. PubMed ID: 17136517
[TBL] [Abstract][Full Text] [Related]
16. Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.
Portugal GS; Wilkinson DS; Turner JR; Blendy JA; Gould TJ
Neurobiol Learn Mem; 2012 May; 97(4):482-94. PubMed ID: 22521799
[TBL] [Abstract][Full Text] [Related]
17. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
[TBL] [Abstract][Full Text] [Related]
18. Impairment of contextual fear extinction by chronic nicotine and withdrawal from chronic nicotine is associated with hippocampal nAChR upregulation.
Kutlu MG; Oliver C; Huang P; Liu-Chen LY; Gould TJ
Neuropharmacology; 2016 Oct; 109():341-348. PubMed ID: 27378334
[TBL] [Abstract][Full Text] [Related]
19. Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.
Marks MJ; Wageman CR; Grady SR; Gopalakrishnan M; Briggs CA
Biochem Pharmacol; 2009 Oct; 78(7):795-802. PubMed ID: 19481067
[TBL] [Abstract][Full Text] [Related]
20. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
